The Impact of Statin Therapy in the Covid-19 Patients
NCT05238402 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 707
Last updated 2022-02-14
Summary
In the retrospective case series, consecutive COVID-19 patients admitted from June 1 to December 31, 2020, were analyzed. A 1:1 matched cohort was created by propensity score-matched analysis. Demographic data, laboratory findings, comorbidities, treatments, and in-hospital outcomes were collected and compared between COVID-19 patients with and without statin use.
Conditions
Interventions
- DRUG
-
Statin
Statin on COVID 19 patienst
Sponsors & Collaborators
-
Antalya Training and Research Hospital
lead OTHER_GOV
Eligibility
- Min Age
- 40 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-06-01
- Primary Completion
- 2020-12-31
- Completion
- 2021-03-31
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
Low-dose Statins and Nutraceuticals in High-intensity Statin-intolerant Patients
NCT02001883 ·Status: UNKNOWN ·Phase: PHASE4
-
Effect of PCSK9 Inhibitors on Coronary Atherosclerotic Plaques Derived From Optical Coherence Tomography
NCT06520904 ·Status: RECRUITING ·Phase: PHASE4
-
Effective Dose of Statin Post PCI
NCT04923152 ·Status: COMPLETED ·Phase: NA
-
The Effect of Statin Use on Vascular Function in Hypertensive Subjects
NCT00181181 ·Status: TERMINATED ·Phase: PHASE4
-
The Effects of Atorvastatin in Patients With Atherosclerosis
NCT00115817 ·Status: COMPLETED ·Phase: PHASE3
-
Implications for Treatment of the Metabolic Syndrome
NCT00666029 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Statin for Elderly Patients With Atherosclerotic Cardiovascular Disease
NCT04826354 ·Status: COMPLETED ·Phase: PHASE4
-
Anti-inflammatory Effect of Atorvastatin in Atherosclerotic Plaques Assessed by FDG-PET Imaging
NCT00920101 ·Status: UNKNOWN ·Phase: PHASE4
-
Role of Statin Therapy in Prevention of Anthracycline-Induced Cardiotoxicity
NCT05792293 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
An Observational Study of Statin Treatment Induced HDL Changes
NCT01551784 ·Status: COMPLETED
-
Effect of Atorvastatin on Subclinical Atherosclerosis
NCT04101136 ·Status: UNKNOWN ·Phase: NA
-
The Role of Atorvastatin on Monocyte Function in Patients With Coronary Artery Disease and Hypercholesterolemia
NCT00329069 ·Status: COMPLETED ·Phase: NA
-
Efficacy Study of p38 Kinase Inhibitor to Treat Patients With Atherosclerosis
NCT00570752 ·Status: COMPLETED ·Phase: PHASE2
-
Long-term Pleiotropic Effect of Statins in Patients With Peripheral Arterial Disease
NCT01041729 ·Status: COMPLETED ·Phase: PHASE4
-
Intensive Statin Therapy Effect on Post-Operative Atrial Fibrillation (POAF)
NCT02029534 ·Status: UNKNOWN ·Phase: PHASE4
-
Preoperative Statin Use and Major Adverse Cardiovascular Events in Liver Transplant Recipients
NCT07089589 ·Status: COMPLETED
-
Statin Immune Study
NCT02984293 ·Status: COMPLETED ·Phase: PHASE4
-
Colchicine Effect on Perivascular Inflammation Index on Coronary CTA
NCT05347316 ·Status: UNKNOWN ·Phase: PHASE1
-
Evaluation of Statin Mechanism Preventing Cardiovascular Disease by Post-hoc Analysis of Treating to New Targets Study
NCT03073863 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Statin Therapy on Vascular Properties and Outcomes in Diastolic Heart Failure Patients
NCT00585611 ·Status: TERMINATED ·Phase: NA
-
Longitudinal Study of Multi-Analyte Profile for Dyslipidemia
NCT01441908 ·Status: UNKNOWN ·Phase: NA
-
Effect of Statins on Lipid Levels Following the First Acute Coronary Event (MK-0000-204)
NCT01245738 ·Status: COMPLETED
-
Statin Therapy in Heart Failure: Potential Mechanisms of Benefit
NCT00233480 ·Status: COMPLETED ·Phase: PHASE4
-
Atorvastatin Pre-Treatment Influences the Risk of Percutaneous Coronary Intervention Study
NCT00469326 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Statins on Asthma Control in Smokers With Asthma
NCT00463827 ·Status: COMPLETED ·Phase: PHASE2